Serum tumor marker levels at diagnosis were CEA 17.5 ng/ml; Sialyl Lewis X‐i (SLX) 68.2 U/ml; pro‐GRP 299.4 pg/ml; and NSE 14.2 ng/ml. The gene discussed is CEACAM5; the disease is neoplasm.